News
News
All News
September 2, 2020
Akoya Biosciences Strengthens Leadership Team with Spatial Biology and Molecular Pathology Experts
Akoya names Niro Ramachandran, Ph.D. as Chief Business Officer and Gavin Gordon, Ph.D. as Vice President of Clinical Market Development. MENLO PARK, Calif. — September 2, […]
Continue Reading
August 12, 2020
Landmark Cell Publication Reveals Novel Spatial Biology Discoveries Enabled by the CODEX® Platform
New peer-reviewed paper outlines novel organizing principles and spatial interactions between “neighborhoods” of cells in the tumor microenvironment of colorectal cancer. MENLO PARK, Calif. — August […]
Continue Reading
December 5, 2019
Akoya Biosciences Raises $50 Million in New Financing
MENLO PARK, CA — December 5, 2019 — Akoya Biosciences, Inc., The Spatial Biology Company™, today announced the completion of a $50 million financing from both […]
Continue Reading
November 8, 2019
Akoya Expands Spatial Biology Portfolio with Optimized PD-1/PD-L1 Panels for Melanoma and Lung Cancer
MENLO PARK, CA — November 8, 2019 — Akoya Biosciences, Inc., The Spatial Biology Company™, today announced that it has launched two new multiplex immunofluorescence kits…
Continue Reading
November 6, 2019
Akoya Biosciences to Showcase New Multiplexed Imaging Data from Its Spatial Biology Platforms at SITC 2019
MENLO PARK, CA — November 6, 2019 — Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that data generated with its CODEX® and Phenoptics™ multiplex…
Continue Reading
November 5, 2019
Precision for Medicine and Akoya Partner to Develop Advanced Liquid Biopsy and Tissue Biomarker Tests
MENLO PARK, CA and HOUSTON, TX , November 5, 2019 – Akoya Biosciences, The Spatial Biology Company™ today announced a strategic alliance with Precision for Medicine…
Continue Reading
July 18, 2019
Study Shows Spatial Biology Is Essential for Predicting Response to Immuno-Oncology Treatment
MENLO PARK, CA — July 18, 2019 — Akoya Biosciences, Inc., The Spatial Biology Company™, announced today that an in-depth comparison of immuno-oncology biomarker…
Continue Reading
April 2, 2019
Akoya Biosciences Appoints Joseph Driscoll as Chief Financial Officer
MENLO PARK, Calif.–(BUSINESS WIRE)–Akoya Biosciences, Inc., today announced the appointment of Joseph Driscoll as Chief Financial Officer…
Continue Reading